 CAMBRIDGE, Mass., March 16, 2021 PRNewswire -- Cogent Biosciences, Inc. Nasdaq: COGT, a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced financial results for the fourth quarter ended December 31, 2020 and provided several corporate updates. 